Analyst Upgrades and Downgrades For the Week of September 9th

September 13th:

Upgrades:

• Borr Drilling (BORR): Upgraded from In-line to Outperform by Evercore ISI, with a price target of $9.
• Federal Realty (FRT): Upgraded from Neutral to Buy by Citigroup, with a new price target of $135 (up from $120).
• Medical Properties Trust (MPW): Upgraded from Neutral to Buy by Colliers Securities, with a price target of $6.5.
• Sabra Health Care REIT (SBRA): Upgraded from Neutral to Buy by Citigroup, with a new price target of $20 (up from $17).
• Sunstone Hotel (SHO): Upgraded from Underweight to Equal Weight by Wells Fargo, with a price target of $10.5.
• SL Green Realty (SLG): Upgraded from Sell to Neutral by Citigroup, with a new price target of $66 (up from $44).
• Xenia Hotels (XHR): Upgraded from Equal Weight to Overweight by Wells Fargo, with a price target of $15 (down from $16).
• Eni S.p.A. (E): Upgraded from Underperform to Neutral by Exane BNP Paribas.

Downgrades:

• Alexandria RE (ARE): Downgraded from Buy to Neutral by Citigroup, with a price target of $125 (down from $130).
• Sendas Distribuidora S.A. (ASAI): Downgraded from Buy to Neutral by BofA Securities.
• AstraZeneca (AZN): Downgraded from Hold to Sell by Deutsche Bank.
• Capri Holdings (CPRI): Downgraded from Buy to Neutral by Citigroup, with a price target of $41.
• CubeSmart (CUBE): Downgraded from Buy to Neutral by UBS, with a price target of $54 (up from $53).
• Fulcrum Therapeutics (FULC): Downgraded from Buy to Neutral by H.C. Wainwright, with a price target of $4 (down from $17).
• Garmin (GRMN): Downgraded from Equal Weight to Underweight by Barclays, with a price target of $133 (down from $181).
• Halliburton (HAL): Downgraded from Outperform to Sector Perform by RBC Capital Markets, with a price target of $37 (down from $44).
• Moderna (MRNA): Multiple downgrades:
• From Outperform to Perform by Oppenheimer.
• From Neutral to Underweight by JP Morgan, with a price target of $70 (down from $88).
• From Buy to Hold by Jefferies, with a price target of $65 (down from $120).
• Nabors Industries (NBR): Downgraded from Buy to Neutral by Citigroup, with a price target of $75 (down from $110).
• Roche Hldg (RHHBY): Downgraded from Hold to Sell by Deutsche Bank.
• RLJ Lodging Trust (RLJ): Downgraded from Equal Weight to Underweight by Wells Fargo, with a price target of $9 (down from $11).
• Voya Financial (VOYA): Downgraded from Strong Buy to Market Perform by Raymond James.
• Manitex Intl (MNTX): Downgraded from Outperform to Market Perform by Northland Capital.

Coverage Initiated:

• Arm Holdings plc (ARM): Initiated with an Outperform rating by Raymond James, price target of $160.
• Constellation Energy (CEG): Initiated with a Hold rating by Jefferies, price target of $186.
• GE Vernova (GEV): Initiated with an Outperform rating by BMO Capital Markets, price target of $245.
• Kiniksa Pharmaceuticals (KNSA): Initiated with a Buy rating by Jefferies, price target of $40.
• Nature’s Sunshine (NATR): Initiated with a Buy rating by Canaccord Genuity, price target of $18.
• NRG Energy (NRG): Initiated with a Hold rating by Jefferies, price target of $82.
• Oruka Therapeutics (ORKA): Initiated with a Buy rating by Jefferies, price target of $40.
• Public Service (PEG): Initiated with a Hold rating by Jefferies, price target of $85.
• NuScale Power (SMR): Initiated with an Outperform rating by CLSA, price target of $11.
• SolarWinds (SWI): Initiated with a Sector Perform rating by Scotiabank.
• TKO Group Holdings (TKO): Initiated with a Buy rating by Pivotal Research Group, price target of $170.
• Talen Energy (TLN): Initiated with a Buy rating by Jefferies, price target of $226.
• Vistra Corp. (VST): Initiated with a Buy rating by Jefferies, price target of $99.
• Haemonetics (HAE): Initiated with a Buy rating by CL King, price target of $116.
• Dorman Products (DORM): Initiated with a Market Outperform rating by CJS Securities, price target of $134.

September 12th:

Upgrades (Thursday, September 12, 2024):

• Bill.com ($BILL)
  • Brokerage Firm: Exane BNP Paribas
  • Ratings Change: Neutral → Outperform
  • Price Target: $90
• Diageo plc ($DEO)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral → Buy
• PotlatchDeltic ($PCH)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral → Buy
  • Price Target: $51
• Roku ($ROKU)
  • Brokerage Firm: Wolfe Research
  • Ratings Change: Peer Perform → Outperform
  • Price Target: $93
• Champions Oncology ($CSBR)
  • Brokerage Firm: Craig Hallum
  • Ratings Change: Hold → Buy
  • Price Target: $6
• Seadrill Ltd ($SDRL)
  • Brokerage Firm: Citigroup
  • Ratings Change: Neutral → Buy

Downgrades (Thursday, September 12, 2024):

• Interpublic ($IPG)
  • Brokerage Firm: UBS
  • Ratings Change: Neutral → Sell
  • Price Target: $34 → $29
• Micron ($MU)
  • Brokerage Firm: Exane BNP Paribas
  • Ratings Change: Outperform → Underperform
  • Price Target: $140 → $67
• Nordic American Tanker ($NAT)
  • Brokerage Firm: Jefferies
  • Ratings Change: Buy → Hold
  • Price Target: $4
• Simon Properties ($SPG)
  • Brokerage Firm: Stifel
  • Ratings Change: Buy → Hold
  • Price Target: $157.5 → $159
• TEN, Ltd. ($TEN)
  • Brokerage Firm: Jefferies
  • Ratings Change: Buy → Hold
  • Price Target: $31 → $27
• Fulcrum Therapeutics ($FULC)
  • Brokerage Firm: Cantor Fitzgerald
  • Ratings Change: Overweight → Neutral
• Transocean ($RIG)
  • Brokerage Firm: Citigroup
  • Ratings Change: Buy → Neutral
• Fulcrum Therapeutics ($FULC)
  • Brokerage Firm: Stifel
  • Ratings Change: Buy → Hold
• Fulcrum Therapeutics ($FULC)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral → Underperform
  • Price Target: $10 → $2
• Fulcrum Therapeutics ($FULC)
  • Brokerage Firm: Leerink Partners
  • Ratings Change: Outperform → Market Perform
  • Price Target: $4
• Fulcrum Therapeutics ($FULC)
  • Brokerage Firm: RBC Capital Markets
  • Ratings Change: Outperform → Sector Perform
  • Price Target: $15 → $4

Coverage Initiated (Thursday, September 12, 2024):

• Asbury Automotive ($ABG)
  • Brokerage Firm: Stephens
  • Ratings Change: Equal-Weight
  • Price Target: $216
• AutoNation ($AN)
  • Brokerage Firm: Stephens
  • Ratings Change: Overweight
  • Price Target: $210
• Apollo Global Management ($APO)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $132
• Ares Management ($ARES)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $156
• Franklin Resources ($BEN)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $20
• BlackRock ($BLK)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $1000
• Benitec Biopharma ($BNTC)
  • Brokerage Firm: Guggenheim
  • Ratings Change: Buy
  • Price Target: $17
• Bridge Investment Group ($BRDG)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $11
• Blackstone ($BX)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $163
• Carlyle Group ($CG)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $42
• Carvana ($CVNA)
  • Brokerage Firm: Stephens
  • Ratings Change: Overweight
  • Price Target: $190
• Evercore ($EVR)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $258
• Flutter Entertainment ($FLUT)
  • Brokerage Firm: Barclays
  • Ratings Change: Overweight
  • Price Target: $263
• Group 1 Auto ($GPI)
  • Brokerage Firm: Stephens
  • Ratings Change: Equal-Weight
  • Price Target: $394
• Houlihan Lokey ($HLI)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Underweight
  • Price Target: $149
• Hamilton Lane ($HLNE)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $156
• Inozyme Pharma ($INZY)
  • Brokerage Firm: Stifel
  • Ratings Change: Buy
  • Price Target: $16
• Invesco ($IVZ)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Underweight
  • Price Target: $16
• Janus Henderson Group ($JHG)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $37
• KKR ($KKR)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $130
• Lithia Motors ($LAD)
  • Brokerage Firm: Stephens
  • Ratings Change: Overweight
  • Price Target: $360
• Lazard ($LAZ)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $51
• LPL Financial ($LPLA)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $235
• Moelis ($MC)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $70
• Blue Owl Capital ($OWL)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $18.5
• Penske Auto ($PAG)
  • Brokerage Firm: Stephens
  • Ratings Change: Equal-Weight
  • Price Target: $161
• Raymond James ($RJF)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $138
• Rocket Lab USA ($RKLB)
  • Brokerage Firm: JMP Securities
  • Ratings Change: Market Perform
• Sonic Automotive ($SAH)
  • Brokerage Firm: Stephens
  • Ratings Change: Equal-Weight
  • Price Target: $64
• Charles Schwab ($SCHW)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight
  • Price Target: $70
• Stifel Financial ($SF)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $101
• Sprouts Farmers Market ($SFM)
  • Brokerage Firm: RBC Capital Markets
  • Ratings Change: Sector Perform
  • Price Target: $107
• TPG Inc. ($TPG)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $60
• T. Rowe Price ($TROW)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight

September 10th:

Upgrades

• Alcon (ALC): RBC Capital Mkts upgraded from Sector Perform to Outperform. Price target not provided.
• CrossFirst Bankshares (CFB): Janney upgraded from Neutral to Buy with a price target of $21.
• Delek US Holdings (DK): JP Morgan upgraded from Underweight to Neutral, with the price target raised from $23 to $26.
• DraftKings (DKNG): Exane BNP Paribas upgraded from Underperform to Neutral. Price target not provided.
• Equity Residential (EQR): Deutsche Bank upgraded from Hold to Buy, with the price target increased from $62 to $83.
• Johnson Controls (JCI): BofA Securities upgraded from Neutral to Buy, with the price target raised from $76to $80.
• Oracle (ORCL): JMP Securities upgraded from Market Perform to Market Outperform, with a price target of $175.
• Relay Therapeutics (RLAY): Jefferies upgraded from Hold to Buy, with the price target raised from $10.6 to $16.

Downgrades

• Bionano Genomics (BNGO): BTIG Research downgraded from Buy to Neutral. Price target not provided.
• Coca-Cola European Partners (CCEP): Exane BNP Paribas downgraded from Outperform to Neutral, with a price target of $81.
• Costco (COST): Redburn Atlantic downgraded from Buy to Neutral, with the price target raised from $860 to $890.
• Methanex (MEOH): Barclays downgraded from Overweight to Equal Weight, with the price target reduced from $56 to $44.
• Nutrien (NTR): Goldman downgraded from Buy to Neutral, with the price target cut from $69 to $53.
• Relay Therapeutics (RLAY): Oppenheimer downgraded from Outperform to Perform. Price target not provided.
• Limoneira (LMNR): Lake Street downgraded from Buy to Hold. Price target not provided.
• Remy Cointreau (REMYF): Exane BNP Paribas downgraded from Outperform to Neutral. Price target not provided.
• Deutsche Telekom (DTEGY): UBS downgraded from Buy to Neutral. Price target not provided.
• ASOS (ASOMF): Barclays downgraded from Equal Weight to Underweight. Price target not provided.
• L’Oreal (LRLCY): Exane BNP Paribas downgraded from Neutral to Underperform. Price target not provided.

Coverage Initiated

• CubeSmart (CUBE): RBC Capital Mkts initiated coverage with an Outperform rating and a price target of $56.
• CVRx, Inc. (CVRX): Cantor Fitzgerald initiated coverage with an Overweight rating and a price target of $14.
• Dell (DELL): Susquehanna initiated coverage with a Neutral rating and a price target of $120.
• Estee Lauder (EL): B. Riley Securities initiated coverage with a Neutral rating and a price target of $95.
• e.l.f. Beauty (ELF): B. Riley Securities initiated coverage with a Buy rating and a price target of $175.
• Extra Space Storage (EXR): RBC Capital Mkts initiated coverage with a Sector Perform rating and a price target of $180.
• GE Aerospace (GE): Bernstein initiated coverage with an Outperform rating and a price target of $201.
• Haemonetics (HAE): BTIG Research initiated coverage with a Buy rating and a price target of $112.
• Honest Company (HNST): B. Riley Securities initiated coverage with a Buy rating and a price target of $6.5.
• Harmony Biosciences (HRMY): UBS initiated coverage with a Buy rating and a price target of $56.
• Longboard Pharmaceuticals (LBPH): Truist initiated coverage with a Buy rating and a price target of $60.
• MKS Instruments (MKSI): Cantor Fitzgerald initiated coverage with an Overweight rating and a price target of $140.
• Phibro Animal Health (PAHC): JP Morgan initiated coverage with a Neutral rating and a price target of $22.
• ProKidney Corp. (PROK): Guggenheim initiated coverage with a Buy rating and a price target of $6.
• Public Storage (PSA): RBC Capital Mkts initiated coverage with a Sector Perform rating and a price target of $358.
• Skye Bioscience (SKYE): JMP Securities initiated coverage with a Market Outperform rating and a price target of $15.
• SKYX Platforms (SKYX): ROTH MKM initiated coverage with a Buy rating and a price target of $2.
• Stryker (SYK): Wolfe Research initiated coverage with an Outperform rating and a price target of $405.
• Ulta Beauty (ULTA): B. Riley Securities initiated coverage with a Sell rating and a price target of $300.
• Zimmer Biomet (ZBH): Wolfe Research initiated coverage with a Peer Perform rating. Price target not provided.
• Kura Sushi (KRUS): Northcoast initiated coverage with a Buy rating and a price target of $79.
• Meta Platforms (META): DA Davidson initiated coverage with a Buy rating and a price target of $600.
• Butterfly Network (BFLY): Lake Street initiated coverage with a Buy rating and a price target of $3.
• Alphabet A (GOOGL): DA Davidson initiated coverage with a Neutral rating and a price target of $170.
• Similarweb (SMWB): Northland Capital initiated coverage with an Outperform rating and a price target of $15.

September 9th:

Upgrades:

1. Celestica (CLS): Upgraded from Hold to Buy; PT $58.
2. ExlService (EXLS): Upgraded from Hold to Buy; PT raised from $35 to $42.
3. Fulcrum Therapeutics (FULC): Upgraded from Underperform to Neutral; PT raised from $5 to $10.
4. MarineMax (HZO): Upgraded from Neutral to Buy; PT raised from $40 to $44.
5. JetBlue Airways (JBLU): Upgraded from Underperform to Neutral; PT raised from $3 to $6.
6. Janus Henderson Group (JHG): Upgraded from Sell to Neutral; PT raised from $33 to $37.
7. LGI Homes (LGIH): Upgraded from Underperform to Neutral; PT raised from $97 to $125.
8. Nucor (NUE): Upgraded from Neutral to Overweight; PT raised from $170 to $174.
9. Steel Dynamics (STLD): Upgraded from Underweight to Neutral; PT raised from $120 to $131.
10. Texas Capital (TCBI): Upgraded from Underperform to Buy; PT raised from $51 to $77.
11. Travere Therapeutics (TVTX): Upgraded from Neutral to Buy; PT $25.
12. U.S. Steel (X): Upgraded from Neutral to Overweight; PT raised from $40 to $42.
13. Thomson Reuters (TRI): Upgraded from Sector Perform to Outperform.
14. Wal-Mart de Mexico (WMMVY): Upgraded from Hold to Buy.
15. PennantPark Investment (PNNT): Upgraded from Sell to Neutral; PT $6.

Downgrades:

1. Consensus Cloud Solutions (CCSI): Downgraded from Neutral to Underweight; PT raised from $19 to $21.
2. Church & Dwight (CHD): Downgraded from Overweight to Equal-Weight; PT $110.
3. Colgate-Palmolive (CL): Downgraded from Buy to Hold; PT raised from $107 to $109.
4. Camden Property (CPT): Downgraded from Outperform to Sector Perform; PT $122.
5. BRP Inc. (DOOO): Downgraded from Sector Outperform to Sector Perform.
6. Fox Corporation (FOXA): Downgraded from Buy to Neutral.
7. Huntington Ingalls (HII): Downgraded from Overweight to Neutral; PT raised from $280 to $285.
8. Invitation Homes (INVH): Downgraded from Outperform to Sector Perform; PT $37 to $36.
9. National Storage Affiliates (NSA): Downgraded from Overweight to Sector Weight.
10. Ubisoft (UBSFY): Downgraded from Overweight to Neutral.
11. Subsea 7 SA (SUBCY): Downgraded from Outperform to Neutral.
12. Remy Cointreau (REMYF): Downgraded from Buy to Hold.
13. Kering SA (PPRUY): Downgraded from Equal Weight to Underweight by Barclays, and from Outperform to Sector Perform by RBC Capital Mkts.
14. Nestle (NSRGY): Downgraded from Overweight to Equal Weight.
15. Adidas AG (ADDYY): Downgraded from Overweight to Equal Weight.
16. Sendas Distribuidora S.A. (ASAI): Downgraded from Overweight to Neutral.
17. Marathon Petroleum (MPC): Downgraded from Buy to Sell.
18. CVR Energy (CVI): Downgraded from Hold to Sell.
19. PBF Energy (PBF): Downgraded from Hold to Sell.
20. Par Pacific (PARR): Downgraded from Buy to Hold.

Coverage Initiated:

1. Atmos Energy (ATO): Initiated with Buy; PT $144.
2. Enliven Therapeutics (ELVN): Initiated with Buy; PT $37.
3. Euroseas (ESEA): Initiated with Buy; PT $60.
4. GE HealthCare (GEHC): Initiated with Neutral; PT $90.
5. Geron (GERN): Initiated with Outperform; PT $7.
6. Ironwood Pharma (IRWD): Initiated with Market Perform; PT $5.
7. Jasper Therapeutics (JSPR): Initiated with Market Outperform; PT $70.
8. Merchants Bancorp (MBIN): Initiated with Equal-Weight; PT $54.
9. Protagonist Therapeutics (PTGX): Initiated with Buy; PT $60.
10. Block (SQ): Initiated with Neutral; PT $70.
11. BBB Foods (TBBB): Initiated with Hold; PT $33.
12. Southern States Bancshares (SSBK): Initiated with Outperform.
13. Galapagos NV (GLPG): Initiated with Market Perform; PT $24.
14. Wave Life Sciences (WVE): Initiated with Overweight; PT $10.
15. Seadrill Ltd (SDRL): Initiated with Outperform.